Keyphrases
Meta-analysis
100%
COVID-19
100%
Angiotensin-converting Enzyme 2 (ACE2)
100%
Transmembrane Protease Serine 2 (TMPRSS2)
100%
Sequencing Studies
40%
Airway
40%
Single-cell RNA Sequencing (scRNA-seq)
40%
Cell-type-specific Gene Expression
40%
Therapeutic Intervention
20%
Interleukin-6
20%
Type-specific
20%
Expression Pattern
20%
Lung
20%
Lung Tissue
20%
Protease
20%
Expression Level
20%
Tumor Necrosis Factor-α
20%
Lung Parenchyma
20%
Viral Entry
20%
Immune Function
20%
Interleukin-1β
20%
Alveoli
20%
Secretory Cells
20%
Molecular Pathways
20%
Nasal Tissue
20%
Entry Factors
20%
Complement Pathway
20%
Gut Tissue
20%
Respiratory Epithelial Cells
20%
Nasal Airway
20%
Nasal Passage
20%
Alveolar Type II Cells
20%
Viral Tropism
20%
Cellular Entry
20%
Medicine and Dentistry
Meta-Analysis
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Angiotensin Converting Enzyme 2
100%
RNA Sequence
40%
COVID-19
40%
Lung
40%
Gut
20%
Epithelial Cell
20%
Tumor Necrosis Factor
20%
Virus Entry
20%
Lung Parenchyma
20%
Immune Function
20%
Proteinase
20%
Interleukin 1
20%
Secretory Cell
20%
Alveolar Type II Cells
20%
Viral Tropism
20%
Interleukin 6
20%
Biochemistry, Genetics and Molecular Biology
Angiotensin-Converting Enzyme 2
100%
TMPRSS2
100%
SARS Coronavirus
100%
RNA Sequence
40%
Coronavirinae
40%
Interleukin-1
20%
Immunity
20%
Virus Entry
20%
Viral Tropism
20%
Tumor Necrosis Factor
20%
Interleukin 6
20%
Protease
20%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Angiotensin
100%
Airway
60%
COVID-19
40%
RNA Sequence
40%
Viral Entry
20%
Tumor Necrosis Factor
20%
Immunity
20%
Interleukin 6
20%
Interleukin 1
20%
Lung Parenchyma
20%
Viral Tropism
20%
Secretory Cell
20%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Angiotensin Converting Enzyme 2
100%
RNA-Sequencing
40%
Coronavirinae
40%
Diseases
40%
Tumor Necrosis Factor
20%
Proteinase
20%
Interleukin 1
20%
Interleukin 6
20%